TCI Wealth Advisors’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,138
Closed -$4.37K 2433
2023
Q1
$4.37K Hold
1,138
﹤0.01% 1622
2022
Q4
$5.64K Hold
1,138
﹤0.01% 1439
2022
Q3
$5K Hold
1,138
﹤0.01% 1542
2022
Q2
$5K Buy
+1,138
New +$4.94K ﹤0.01% 1563
2022
Q1
Sell
-687
Closed -$5K 2528
2021
Q4
$5K Buy
687
+155
+29% +$963 ﹤0.01% 1749
2021
Q3
$3K Buy
+532
New +$3.07K ﹤0.01% 2056
2021
Q2
Sell
-225
Closed -$2K 2497
2021
Q1
$2K Sell
225
-12,775
-98% -$104K ﹤0.01% 1958
2020
Q4
$84K Hold
13,000
0.04% 252
2020
Q3
$47K Hold
13,000
0.02% 318
2020
Q2
$60K Hold
13,000
0.03% 279
2020
Q1
$44K Hold
13,000
0.02% 334
2019
Q4
$66K Hold
13,000
0.03% 330
2019
Q3
$31K Hold
13,000
0.01% 417
2019
Q2
$28K Hold
13,000
0.01% 413
2019
Q1
$35K Hold
13,000
0.02% 406
2018
Q4
$62K Hold
13,000
0.03% 282
2018
Q3
$123K Sell
13,000
-1,000
-7% -$9.61K 0.05% 212
2018
Q2
$136K Buy
14,000
+4,000
+40% +$42.2K 0.06% 185
2018
Q1
$105K Buy
10,000
+6,000
+150% +$59.3K 0.05% 214
2017
Q4
$26K Buy
+4,000
New +$24.7K 0.01% 453
2016
Q4
Sell
-362
Closed -$1K 1471
2016
Q3
$1K Buy
+362
New +$1.05K ﹤0.01% 1258
2014
Q3
Sell
-1,000
Closed -$12K 927
2014
Q2
$12K Hold
1,000
0.01% 440
2014
Q1
$15K Hold
1,000
0.01% 363
2013
Q4
$15K Hold
1,000
0.01% 374
2013
Q3
$17K Hold
1,000
0.01% 307
2013
Q2
$17K Buy
+1,000
New +$16.2K 0.01% 320

Other funds holding IMGN

TCI Wealth Advisors's IMGN Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Immunogen Inc (IMGN) in Q2 2023, closing a stake of 1,138 shares — an estimated $4.37K sold.

TCI Wealth Advisors first reported a position in IMGN in Q2 2013 and held it in 26 quarters. The position peaked at $136K in Q2 2018. 266 funds tracked by Wall St. Rank hold IMGN as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Immunogen Inc position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 1,138 Immunogen Inc shares in Q2 2023, an estimated $4.37K.
  • TCI Wealth Advisors first reported a position in Immunogen Inc in Q2 2013 and held it in 26 quarters.
  • TCI Wealth Advisors's Immunogen Inc position peaked at $136K in Q2 2018.
  • 266 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.